Pacira Pharmaceuticals reported $6.97M in Interest Expense on Debt for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Acelrx Pharmaceuticals ACRX:US $ 672K 82K
Adamas Pharmaceuticals ADMS:US 3.43M 42K
Aerie Pharmaceuticals AERI:US $ 6.9M 0.03M
Amerisourcebergen ABC:US $ 35.18M 0.61M
Antares Pharma ATRS:US $ 0.96M 0.02M
Biodelivery Sciences International BDSI:US $ 1.4M 716K
Bristol Myers Squibb BMY:US $ 353M 2M
Endo International Ordinary Shares ENDP:US $ 134.7M 0.65M
Flexion Therapeutics FLXN:US $ 5.19M 10K
JAZZ PHA JAZZ:US $ 28.58M 0.4M
Johnson & Johnson JNJ:US $ 63M 24M
Lannett LCI:US $ 12.63M 0.86M
Ligand Pharmaceuticals LGND:US $ 5.54M 0.86M
Nektar Therapeutics NKTR:US $ 13.3M 5.11M
Omeros OMER:US $ 4.9M 3.09M
Pacira Pharmaceuticals PCRX:US $ 6.97M 0.09M
Revance Therapeutics RVNC:US $ 1.56M 2.85M
Supernus Pharmaceuticals SUPN:US $ 6.1M 1.09M
Teva Pharmaceutical TEVA:IT 239M 2M
Xeris Pharmaceuticals Inc XERS:US $ 1.79M 2.8M
Xoma XOMA:US $ 289K 71K
Zoetis ZTS:US $ 57M 1M